Fluocinolone acetonide intraviteal implant
- BNF:
- 11.4.1
- Status:
- Do Not Prescribe (DNP), Red
- Decision Date:
- December 2013
Comments
RED:
- NICE TA953 - for treating chronic diabetic macular oedema. (Replaces TA301 and TA613) (Decision date - April 2024)
- NICE TA590 - for treating recurrent non-infectious uvetitis. (Decision date - August 2019)
Do Not Prescribe (DNP) Drug Classifications
- 6: Have NICE guidance that recommends they should not be used
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
search again